1. Home
  2. HLT vs TAK Comparison

HLT vs TAK Comparison

Compare HLT & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hilton Worldwide Holdings Inc.

HLT

Hilton Worldwide Holdings Inc.

HOLD

Current Price

$317.36

Market Cap

67.5B

ML Signal

HOLD

Logo Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

TAK

Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

HOLD

Current Price

$18.67

Market Cap

56.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLT
TAK
Founded
1919
1781
Country
United States
Japan
Employees
N/A
47455
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.5B
56.6B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
HLT
TAK
Price
$317.36
$18.67
Analyst Decision
Buy
Analyst Count
15
0
Target Price
$308.27
N/A
AVG Volume (30 Days)
1.4M
2.9M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
0.20%
2.88%
EPS Growth
N/A
N/A
EPS
6.12
N/A
Revenue
$12,039,000,000.00
N/A
Revenue This Year
$9.74
$0.38
Revenue Next Year
$8.36
$1.02
P/E Ratio
$49.38
$41.25
Revenue Growth
7.74
N/A
52 Week Low
$201.15
$12.99
52 Week High
$333.86
$18.90

Technical Indicators

Market Signals
Indicator
HLT
TAK
Relative Strength Index (RSI) 61.09 58.38
Support Level $288.25 $17.65
Resistance Level $319.61 N/A
Average True Range (ATR) 6.52 0.28
MACD 1.81 0.03
Stochastic Oscillator 92.54 81.61

Price Performance

Historical Comparison
HLT
TAK

About HLT Hilton Worldwide Holdings Inc.

Hilton Worldwide Holdings operates 1.35 million rooms across its 25 brands, serving the premium economy through luxury segments. Hampton and Hilton are the two largest brands, representing 27% and 18%, respectively, of the company's total rooms, as of Dec. 31, 2025. Recent brands launched over the past few years include Home2, Curio, Canopy, Spark, Tru, Tempo, LivSmart, and Outset. Additionally, there is a partnership with Small Luxury Hotels of the World and acquisitions of NoMad and Graduate Hotels. Managed and franchised hotels represent the vast majority of adjusted EBITDA, predominantly from the Americas.

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Share on Social Networks: